1. Home
  2. ACNT vs UNCY Comparison

ACNT vs UNCY Comparison

Compare ACNT & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascent Industries Co.

ACNT

Ascent Industries Co.

N/A

Current Price

$15.26

Market Cap

135.8M

Sector

Industrials

ML Signal

N/A

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$5.22

Market Cap

145.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACNT
UNCY
Founded
1945
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
135.8M
145.3M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
ACNT
UNCY
Price
$15.26
$5.22
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$25.67
AVG Volume (30 Days)
100.6K
2.6M
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
106.72
N/A
EPS
N/A
N/A
Revenue
N/A
$675,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$582.86
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.62
$3.72
52 Week High
$17.92
$8.74

Technical Indicators

Market Signals
Indicator
ACNT
UNCY
Relative Strength Index (RSI) 63.73 38.30
Support Level $13.35 $4.18
Resistance Level $15.46 $5.59
Average True Range (ATR) 0.56 0.73
MACD 0.09 -0.17
Stochastic Oscillator 71.67 29.48

Price Performance

Historical Comparison
ACNT
UNCY

About ACNT Ascent Industries Co.

Ascent Industries Co is a specialty chemicals company focused on the development, production, and distribution of tailored, performance-driven chemical solutions. Its customers are spread across energy, household, industrial and institutional (HII), personal care, coatings, adhesives, sealants and elastomers (CASE), agriculture, water treatment, pulp and paper, construction, automotive, and other industrial markets. The company's core product portfolio includes surfactants, defoamers, lubricating agents, flame retardants, and specialty intermediates, offered in both petroleum-based and bio-based formulations. Geographically, it generates maximum revenue from the United States, followed by Mexico, Canada, Honduras, Colombia, the Netherlands, Costa Rica, Japan, and other markets.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: